Nine of Australia's most renowned scientists have been awarded $4m fellowships by the NHMRC.

How the study of the common honeybee is revolutionising the fields of neurobiology and robotics.

A Queensland PhD student has come up with a rapid diagnostic test for Dengue fever.

The share price of Queensland biotech company Progen Industries has almost tripled in less than six months following promising Phase II clinical trial results for its lead cancer compound and the expectation of more good news in the near future.

The powerful enticement of vegemite on toast encouraged a biologist specialising in the visual systems of bees to make his home in Australia in the '70s. Now, Professor Mandyam Srinivasan has received the Prime Minister's Prize for Science.

ANU researchers have uncovered a neat little system to stop DNA replication in its tracks.

Just as the HPV vaccine Gardasil receives FDA approval, an argument has broken out between the researchers involved in the vaccine's development. So who patented what?

South Australia's rapidly expanding biotechnology industry now has access to AUD$35 million in venture capital, with Bio Innovation SA securing a deal with one of Australia's most successful superannuation funds, MTAA Super.

Profiling proteins is a challenging undertaking. But new research is providing new insights into protein structure and function, reports Susan Williamson.

Should Australia lift its ban on therapeutic cloning? Few topics in Australian science have generated such strong opinions. Ruth Beran reports.

CSIRO Plant Industry researchers have abandoned a project to develop a genetically modified field pea with resistance to the pea weevil, Bruchus pisorum.